View Single Post
Old 12-20-03, 10:47 PM
Salsa's Avatar
Salsa Salsa is offline
ADDvanced Member

Join Date: Nov 2003
Location: Iowa
Posts: 222
Thanks: 0
Thanked 20 Times in 7 Posts
Salsa is on a distinguished road
I've been to your site before when doing all my independent "research" (if you will).

Here are some other things I found and grouped together by chromosome bands that might relate to ADHD, Autism and/or Bipolar Disorder. When available, I list the "Gene Locus" between lines (like these "||").

Arrhythmogenic right ventricular dysplasia 2, 1q42.1-q43
Arrhythmogenic right ventricular dysplasia-2 1q42-q43
Bipolar Affective Disorder |AGT| 1q42-q43
Chediak-Higashi syndrome, |CHS1, LYST|1q42.1-q42.2
Diphenylhydantoin toxicity |EPHX1| 1q42.1
Familial Mediterranean Fever |MEF| 1q42-43
Fetal hydantoin syndrome |EPHX1| 1q42.1
Fumarase deficiency |FH| 1q42.1
Greenberg dysplasia, |LBR, PHA| 1q42.1
{Hypertension, essential, susceptibility to} |AGT, SERPINA8|1q42-q43
Hypoparathyroidism-retardation-dysmorphism syndrome, |TBCE, KCS, KCS1,HRD|1q42-q43
Kenny-Caffey syndrome-1 |TBCE, KCS, KCS1, HRD| 1q42-q43
Left-right axis malformation |EBAF, TGFB4, LEFTY1|1q42.1
Leiomyomatosis and renal cell cancer, |FH| 1q42.1
Longevity |ADPRT| 1q41-q42
Multiple cutaneous and uterine leiomyomata, |FH|1q42.1
Muscular dystrophy, congenital, 1B |MDC1B| 1q42
Myopathy, actin |ACTA1, ASMA, NEM2, NEM1| 1q42.1
Myopathy, nemaline, |ACTA1, ASMA, NEM2, NEM1|1q42.1
Pelger-Huet anomaly, 169400 (3) |LBR, PHA| 1q42.1
{Preeclampsia, susceptibility to} |AGT, SERPINA8| 1q42-q43
{Prostate cancer, susceptibility to}, |PCAP, PRCA2|1q42.2-q43
Retinitis pigmentasa, AR, without hearing loss,|USH2A|1q41
Schizophrenia, |DISC1|1q42.1
Schizophrenia, |DISC2|1q42.1
Stroke/ High Blood Pressure |AGT|1q42-q43
Systemic lupus erythematosus|SLEB1, SLE1|1q41-42
Ventricular tachycardia, stress-induced polymorphic, |RYR2, VTSIP|1q42.1-q43
Xeroderma pigmentosum|ADPRT, PPOL|1q42

3q21q26 syndrome|EVI1|3q26
3-Methylcrotonylglycinuria I |MCCC1, MCCA|3q25-q27
ADULT syndrome, |TP73L, TP63, KET, EEC3, SHFM4, LMS|3q27
Abdominal obesity-metabolic syndrome |AOMS1, SYNX|3q27
Anophthalmia|SOX2, ANOP3|3q26.3-q27
Apnea, postanesthetic |BCHE, CHE1|3q26.1-q26.2
{Autism, susceptibility to, 3} |AUTS3|3q25-q27
[Blood group, P system], |B3GALT3, GLCT3, P|3q25
Cerebral cavernous malformations-3 |CCM3|3q25.2-q27
Cornelia de Lange syndrome |CDL1|3q26.3
Congenital disorder of glycosylation, type Id |ALG3, NOT56L, CDGS4|3q27
{Diabetes mellitus, noninsulin-dependent} |SLC2A2, GLUT2|3q26.1-3q26.3
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3,|TP73L, TP63, KET, EEC3, SHFM4, LMS|3q27
Encephalopathy, familial, with neuroserpin inclusion bodies, |SERPINI1, PI12|3q26
Epilepsy with grand mal seizures on awakening, |CLCN2, EGMA, ECA3|3q26-qter
Epilepsy, childhood absence|CLCN2, EGMA, ECA3|3q26-qter
{Epilepsy, idiopathic generalized, susceptibility to},|EGI3|3q26.1
Epilepsy, juvenile absence |CLCN2, EGMA, ECA3|3q26-qter
Epilepsy, juvenile myoclonic |CLCN2, EGMA, ECA3|3q26-qter
Fanconi-Bickel syndrome|SLC2A2, GLUT2|3q26.1-q26.3
Goiter, multinodular,|MNG3|3q26.1-q26.3
Hay-Wells syndrome|TP73L, TP63, KET, EEC3, SHFM4, LMS|3q27
Hypomagnesemia, primary |CLDN16, PCLN1|603959|3q27
Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitisILVASC|3q27-q28
[Kininogen deficiency]|KNG|3q27
Leukemia, myeloid, acute|MLF1|3q25.1
Leukoencephalopathy with vanishing white matter|EIF2B5, LVWM, CACH, CLE|3q27
Limb-mammary syndrome|TP73L, TP63, KET, EEC3, SHFM4, LMS|3q27
Lymphoma, B-cell|BCL6|3q27
Myelodysplasia syndrome-1 |MDS1|3q26
Ovarian cancer |PIK3CA|3q26.3
Spastic paraplegia 14, autosomal recessive|SPG14|3q27-q28
Split-hand/foot malformation, type 4, |TP73L, TP63, KET, EEC3, SHFM4, LMS|3q27
Sucrose intolerance |SI| 3q25-q26
Thrombocythemia, essential |THPO, MGDF, MPLLG, TPO|3q26.3q27
Thrombophilia due to HRG deficiency (3) |HRG|3q27

Achondroplasia |FGFR3, ACH|4p16.3
Bipolar 4p15.3-p16.1
Bladder cancer, |FGFR3, ACH|4p16.3
{Blepharospasm, primary benign |DRD5, DRD1B, DRD1L2|4p16.1-p15.3
Cervical cancer, somatic, |FGFR3, ACH|4p16.3
Cherubism, |SH3BP2, CRPM|4p16.3
Colorectal cancer, somatic, |FGFR3, ACH|4p16.3
{Congestive heart failure, susceptibility to} |ADRA2C, ADRA2L2|4p16.1
Craniosynostosis, Adelaide type |CRSA, CRS3|4p16
Crouzon syndrome with acanthosis nigricans |FGFR3, ACH|4p16.3
Dystonia, primary cervical |DRD5, DRD1B, DRD1L2|4p16.1-p15.3
Ellis-van Creveld syndrome, |EVC|4p16
Ellis-van Creveld syndrome, |LBN, EVC2|4p16
Epilepsy, partial, with pericentral spikes |EPPS|4p15
Hearing loss, low-frequency sensorineural, |WFS1, WFRS, WFS, DFNA6|4p16.1
Huntington disease-like 3 |HDL3, HLN2|4p15.3
Huntington disease |HD, IT15|4p16.3
{Hypertension, essential, salt-sensitive} |ADD1|4p16.3
Hypochondroplasia, 146000 |FGFR3, ACH|4p16.3
Hypodontia with orofacial cleft, |MSX1, HOX7, HYD1|4p16.1
Hypodontia, autosomal dominant, |MSX1, HOX7, HYD1|4p16.1
Lipodystrophy, familial partial, with decreased subcutaneous fat of face and neck |PPARGC1|4p15.1
Macular dystrophy 2, Bull's eye |MCDR2|4p16.3-p15.2
Mucopolysaccharidosis Ih|IDUA, IDA|4p16.3
Mucopolysaccharidosis Ih/s|IDUA, IDA|4p16.3
Mucopolysaccharidosis Is|IDUA, IDA|4p16.3
Muencke syndrome|FGFR3, ACH|4p16.3
Night blindness, congenital stationary, type 3|PDE6B, PDEB, CSNB3|4p16.3
{Nasopharyngeal carcinoma 1 |NPC1, NPCA1|4p15.1-q12
Parkinson disease 4, autosomal dominant, Lewy body |PARK4|4p15
Phenylketonuria due to dihydropteridine reductase deficiency|QDPR, DHPR|4p15.31
Retinal degeneration, autosomal recessive, prominin-related|PROM1, PROML1, AC133|4p16.2-p12
Retinitis pigmentosa, autosomal recessive|PDE6B, PDEB, CSNB3|4p16.3
{Systemic lupus erythematosus, susceptibility to, 3}|SLEB3|4p16-p15.2
Thanatophoric dysplasia, types I and II,|FGFR3, ACH|4p16.3
Weyers acrodental dysostosis |EVC|4p16
Witkop syndrome |MSX1, HOX7, HYD1| 4p16.1
Wolf-Hirschhorn syndrome|WHCR| 4p16.3
Wolfram syndrome, |WFS1, WFRS, WFS, DFNA6|4p16.1

Autism-like syndrome |AUTS2, KIAA0442|7q11.2
Autism |7q31-35
Basal cell carcinoma, sporadic|SMOH, SMO|7q31-q32
[Body mass index] |BMIQ1|7q32.3
Colorblindness, tritan|OPN1SW, BCP, CBT|7q31.3-q32
Congenital bilateral absence of vas deferens |CFTR, ABCC7, CF, MRP7|7q31.2
Cutis laxa, marfanoid neonatal type|LAMB1|7q31.1-q31.3
Cystic fibrosis|CFTR, ABCC7, CF, MRP7|7q31.2
Deafness, autosomal recessive 14 |DFNB14|7q31
Deafness, autosomal recessive 17 |DFNB17|7q31
Deafness, autosomal recessive 4 |SLC26A4, PDS, DFNB4|7q31
Enlarged vestibular aqueduct |SLC26A4, PDS, DFNB4|7q31
{H. pylori infection, susceptibility to} |PTPRZ1, PTP18|7q31.3
Hemolytic anemia due to bisphosphoglycerate mutase deficiency |BPGM|7q31-q34
Hepatocellular carcinoma, childhood type |MET|7q31
{Hypertrypsinemia, neonatal}|CFTR, ABCC7, CF, MRP7|7q31.2
Lipoamide dehydrogenase deficiency |DLD, LAD, PHE3|7q31-q32
Obesity, morbid, with hypogonadism |LEP, OB|7q31.3
Obesity, severe, due to leptin deficiency |LEP, OB|7q31.3
{Pancreatitis, idiopathic} |CFTR, ABCC7, CF, MRP7|7q31.2
Pendred syndrome |SLC26A4, PDS, DFNB4|7q31
PCOS (Polycystic ovary syndrome) |OB |7q31.3-32.1
Renal cell carcinoma, papillary, familial and sporadic |MET| 7q31
Retinitis pigmentosa-10 |RP10| 7q31-q35
Retinitis pigmentosa-10 |IMPDH1| 7q31.3-q32
Saccharopinuria |AASS| 7q31.3
Speech-language disorder-1 |FOXP2, SPCH1, TNRC10, CAGH44|605317|7q31
Stature QTL 7 |STQTL7|7q31.3
Strabismus |7q32-37 (Duplication of the long arm of chromosome 7)
Sweat chloride elevation without CF |CFTR, ABCC7, CF, MRP7|7q31.2

ADHD |ADRA2 a2-adrenergic receptor |10q24-q26
Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency |CYP17A1, CYP17, P450C17|10q24.3
Alzheimer disease 6|AD6|10q24
Anterior segment mesenchymal dysgenesis and cataract |PITX3|10q25
Antley-Bixler syndrome |FGFR2, BEK, CFD1, JWS| 10q26
Apert syndrome |FGFR2, BEK, CFD1, JWS|10q26
{Autoimmune lymphoproliferative syndrome} |TNFRSF6, APT1, FAS, CD95|10q24.1
Bannayan-Riley-Ruvalcaba syndrome |PTEN, MMAC1|10q23.31
Bannayan-Zonana syndrome |PTEN, MMAC1| 10q23.31
Beare-Stevenson cutis gyrata syndrome |FGFR2, BEK, CFD1, JWS| 10q26
Bipolar Disorder (susceptibility) |10q26
Carboxypeptidase N deficiency |CPN1, SCPN, CPN|10q24.2
Cardiomyopathy, hypertrophic, early-onset fatal |COX15| 10q24
Cataract, congenital |PITX3|10q25
Charcot-Marie-Tooth disease, dominant intermediate 2 |CMTDI2|10q24.1-q25.1
Cholesteryl ester storage disease |LIPA|10q24-q25
{congestive heart failure, susceptibility to} |ADRB1, ADRB1R, RHR| 10q24-q26
Corneal dystrophy, Thiel-Behnke type |CDB2, CDTB|10q24
Cowden disease, 158350 (3) |PTEN, MMAC1|601728|10q23.31
Craniofacial-skeletal-dermatologic dysplasia |FGFR2, BEK, CFD1, JWS|10q26
Craniosynostosis, nonspecific |FGFR2, BEK, CFD1, JWS|10q26
Crouzon syndrome |FGFR2, BEK, CFD1, JWS|10q26
{Diabetes mellitus, insulin-dependent, 17} |IDDM17|10q25
Dubin-Johnson syndrome, |ABCC2, CMOAT|10q24
Endometrial carcinoma|PTEN, MMAC1|10q23.31
Endometrial carcinoma (2) |DEC|10q26
Epidermolysis bullosa, generalized atrophic benign, |COL17A1, BPAG2|10q24.3
Epilepsy, partial, with auditory features, |LGI1, EPT|10q24
Gastric cancer, somatic,|FGFR2, BEK, CFD1, JWS|10q26
Glioblastoma |WDR11, DR11, KIAA1351|10q26
Glioblastoma multiforme, somatic |DMBT1| 10q25.3-q26.1
Glioblastoma, somatic |LGI1, EPT| 10q24
Gyrate atrophy of choroid and retina with ornithinemia, B6 responsive or unresponsive |OAT|10q26
Hermansky-Pudlak syndrome|HPS1|10q23.1
Hermansky-Pudlak syndrome|HPS6, RU|10q24.32
Hyperinsulinism-hyperammonemia syndrome|GLUD1|10q23.3
Hypoglobulinemia and absent B cells |BLNK, SLP65| 10q23.2
Jackson-Weiss syndrome |FGFR2, BEK, CFD1, JWS|10q26
Leukemia, T-cell acute lymphocytic |TLX1, HOX11, TCL3|10q24
Lhermitte-Duclos syndrome |PTEN, MMAC1|10q23.31
Medulloblastoma |DMBT1| 10q25.3-q26.1
Medulloblastoma |PEO1, PEO|10q24
Medulloblastoma, desmoplastic|SUFU, SUFUXL, SUFUH|10q24-q25
Meningioma, 156100 (3) |PTEN, MMAC1|10q23.31
Mephenytoin poor metabolizer |CYP2C, CYP2C19|10q24.1-q24.3
Neurofibrosarcoma |MXI1|10q25
Neuropathy, motor and sensory, Russe type |NMSR, HMSNR|10q23.2
Oligodendroglioma |PTEN, MMAC1| 10q23.31
Optic nerve coloboma with renal disease |PAX2| 10q24.3-q25.1
P5CS deficiency |PYCS, GSAS| 10q24.3
Pancreatic lipase deficiency |PNLIP| 10q26.1
Pfeiffer syndrome |FGFR2, BEK, CFD1, JWS| 10q26
Porphyria, congenital erythropoietic |UROS|606938|10q25.2-q26.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions,|C10orf2, TWINKLE, PEO1, PEO| 10q24
{Prostate cancer}, |PTEN, MMAC1|10q23.31
{Prostate cancer, susceptibility to}, |MXI1|10q25
Proteus syndr |PTEN, MMAC1|10q23.31
Renal hypoplasia, isolated |PAX2|10q24.3-q25.1
[Resting heart rate] |ADRB1, ADRB1R, RHR|10q24-q26
Retinitis pigmentosa, autosomal dominant|RGR|10q23
Retinitis pigmentosa, autosomal recessive|RGR|10q23
Retinol binding protein, deficiency of |RBP4|10q24
Saethre-Chotzen syndrome|FGFR2, BEK, CFD1, JWS|10q26
Spastic paraplegia-9 |SPG9|10q23.3-q24.1
Spinocerebellar ataxia, infantile-onset, with sensory neuropathy |IOSCA, SCA8|10q24
Split hand/foot malformation, type 3 |SHFM3, DAC |10q24
Squamous cell carcinoma, burn scar-related, somatic |TNFRSF6, APT1, FAS, CD95|10q24.1
Thyroid carcinoma, follicular, |PTEN, MMAC1| 10q23.31
Tolbutamide poor metabolizer|CYP2C9|10q24
Urofacial syndrome|UFS|10q23-q24
VATER association with hydrocephalus|PTEN, MMAC1|10q23.31
Warfarin sensitivity, |CYP2C9|10q24
Wolman disease |LIPA|10q24-q25

Acyl-CoA dehydrogenase, short-chain, deficiency of |ACADS, SCAD|12q22-qter
Alcohol intolerance, acute |ALDH2|12q24.2
B-cell non-Hodgkin lymphoma, high-grade |BCL7A, BCL7|12q24.1
Bipolar Disorder |P2RX7, P2X7| 12q24.3
Cornea plana congenita, recessive, 217300 (3) |KERA, CNA2|603288|12q22
Diabetes mellitus, noninsulin-dependent, 2 (2) |NIDDM2|601407|12q24.2
Growth retardation with deafness and mental retardation (3) |IGF1|147440|12q22- q24.1
Hepatic adenoma, 142330 (3) |TCF1, HNF1A, MODY3|142410|12q24.2
[Histidinemia] (1) |HAL, HSTD|235800|12q22-q23
Holt-Oram syndrome, 142900 (3) |TBX5|601620|12q24.1
Hyper-IgD syndrome, 260920 (3) |MVK, MVLK|251170|12q24
Leopard syndrome, 151100 (3) |PTPN11, PTP2C, SHP2, NS1|176876|12q24.1
Leukemia, chronic lymphatic |P2RX7, P2X7| 12q24
Male germ cell tumor (2) |MGCT|273300|12q22
Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3) |MMAB|607568|12q24
MODY, type III, 600496 (3) |TCF1, HNF1A, MODY3|142410|12q24.2
Leukemia, juvenile myelomonocytic, 607785 (3) |PTPN11, PTP2C, SHP2, NS1|176876|12q24.1
PCOS (Polycystic Ovarian Syndrome) |12q22-23
Predisposed to Autism |Reelin| 12q24
Schizophrenia |DAO, DAMOX| 12q24

{Asthma} |PHF11, NYREN34|13q14.1
{Autism, susceptibility to, 4} |AUTS4|13q14.2-q14.1
Bare lymphocyte syndrome, type II, complementation group D |RFXAP|13q14
Bladder cancer|RB1|13q14.1-q14.2
[Body mass index] |BMIQ2|13q14
Dementia, familial British |ITM2B, BRI, ABRI, FBD|13q14
Dementia, familial Danish |ITM2B, BRI, ABRI, FBD|13q14
Gastroesophageal reflux |GER| 13q14
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome |SLC25A15, ORNT1, HHH|13q14
[IgE levels QTL]|PHF11, NYREN34|13q14.1
Leukemia, chronic lymphocytic, B-cell|D13S25, DBM|13q14
{Nonsmall cell lung cancer}|DDX26, DICE1|13q14.12-q14.2
Pinealoma with bilateral retinoblastoma|RB1|13q14.1-q14.2
Retinoblastoma |RB1|13q14.1-q14.2
Rhabdomyosarcoma, alveolar|FOXO1A, FKHR|13q14.1
Rieger syndrome, type 2 |RIEG2, RGS2|13q14
Spastic paraplegia 24 |SPG24|13q14
Wilson disease|ATP7B, WND|13q14.3-q21.1

AGAT deficiency |GATM, AGAT|15q15.3
Adiponectin deficiency |APM1, GBP28|3q27
Agenesis of the corpus callosum with peripheral neuropathy |SLC12A6, KCC3A, KCC3B, KCC3, ACCPN|15q13-q14
Albinism, brown oculocutaneous|OCA2, P, PED, D15S12, BOCA|15q11.2-q12
Albinism, ocular, autosomal recessive |OCA2, P, PED, D15S12, BOCA| 15q11.2-q12
Albinism, oculocutaneous, type II |OCA2, P, PED, D15S12, BOCA|15q11.2-q12
Albright hereditary osteodystrophy-2 |AHO2|15q11-q13
Angelman syndrome |UBE3A, ANCR|15q11-q13
{Autism, susceptibility to} |AUTS1, AUT|15q11-q13
GABA-A receptor beta3 and alpha5 subunit gene cluster on chromosome15q11-q13
angelman syndrome (Elizabeth's facial features)
autistic/asperger savant
{Gluten-sensitive enteropathy, susceptibility to}|GSES|15q11-q13
{Hypertriglyceridemia, susceptibility to} |HTGS|15q11.2-q13.1
Juvenile Myoclonic Epilepsy |CHRNA7| 15q13-14
Lymphoma, diffuse large cell|BCL8|15q11-q13
Nanophthalmos 2|NNO2|15q12-q15
Prader-Willi syndrome |PWCR, PWS|15q11
Prader-Willi syndrome |NDN|15q11-q13
Prader-Willi syndrome |SNRPN|15q12
Schizophrenia |CHRNA7| 15q13-14
Spastic paraplegia-6 |SPG6|15q11.1
Spastic paraplegia-11 |SPG11|15q13-q15
[Eye color, brown] |EYCL3|15q11-q15
[Hair color, brown] |HCL3|15q11-q15

Attention deficit-hyperactivity disorder|ADHD|16p13
Bipolar Affective Disorder |SSTR5| 16p13.3
Carbohydrate-deficient glycoprotein syndrome, type I, |PMM2, CDG1|16p13.3-p13.2
Cataract, congenital, with microphthalmia |CATM|16p13.3
Charcot-Marie-Tooth disease, type 1C |LITAF, CMT1C| 16p13.3-p12
Deafness, autosomal dominant 40 |CRYM, DFNA40|16p13.11-p12.3
Epilepsy, myoclonic, infantile |EIM |16p13
Familial Mediterranean fever |MEFV, MEF, FMF|16p13
GABA-transaminase deficiency |ABAT, GABAT|16p13.3
[Glyoxalase II deficiency] |HAGH, GLO2|16p13
Hepatocellular carcinoma |AXIN1, AXIN|16p13.3
{?Hypertension, essential} |SAH| 16p13.11
Liddle syndrome, 177200 |SCNN1B|16p13-p12
Liddle syndrome, 177200 |SCNN1G, PHA1|16p13-p12
Lymphangioleiomyomatosis, somatic |TSC2, LAM| 16p13.3
MHC class II deficiency, complementation group A |MHC2TA, C2TA| 16p13
Microhydranencephaly |MHAC|16p13.3-p12.1
Osteopetrosis, autosomal dominant, type II |CLCN7, CLC7, OPTA2|16p13
Osteopetrosis, recessive |CLCN7, CLC7, OPTA2|16p13
PKDTS, infantile severe, with tuberous sclerosis |PKD|16p13.3
Polycystic kidney disease, adult type I |PKD1|601313|16p13.3-p13.12
Polycystic kidney disease, infantile severe, with tuberous sclerosis|PKDTS|16p13.3
Pseudohypoaldosteronism, type I |SCNN1B|16p13-p12
Pseudohypoaldosteronism, type I |SCNN1G, PHA1|16p13-p12
Pseudoxanthoma elasticum, autosomal dominant |ABCC6, ARA, ABC34, MLP1, PXE|16p13.1
Pseudoxanthoma elasticum, autosomal recessive |ABCC6, ARA, ABC34, MLP1, PXE|16p13.1PXE|16p13.1
Rubenstein-Taybi syndrome |CREBBP, CBP, RSTS|16p13.3
Systemic lupus erythematosus |SLE|16p13.3
Tuberous sclerosis-2 |TSC2, LAM|16p13.3
TSC2 can include:Epilepsy, Autism, Rosacea, Renal & Cardiac Problems
Xeroderma pigmentosum, group F|ERCC4, XPF|16p13.3-p13.13

Adenylosuccinase deficiency |ADSL|22q13.1
Agammaglobulinemia, autosomal recessive |IGLL1, IGO, 5 |22q11.21
{Amyotrophic lateral sclerosis, susceptibility to} |NEFH|22q12.2
Autism, succinylpurinemic |ADSL|22q13.1
Bernard-Soulier syndrome, type B |GP1BB|22q11.2
[Blood group, P system] |A4GALT, PK|22q13.2
{Breast and colorectal cancer, susceptibility to} |CHEK2, RAD53, CHK2, CDS1| 22q12.1
{Breast cancer, susceptibility to} |CHEK2, RAD53, CHK2, CDS1| 22q12.1
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency |SCO2| 22q13
Cat eye syndrome |CECR, CES| 22q11
Cataract, cerulean, type 2 |CRYBB2, CRYB2| 22q11.2-q12.2
Cataract, cerulean, type 2 |CRYB2| 22q11.2-q12.2
Chondrosarcoma, extraskeletal myxoid|EWSR1, EWS| 22q12
Chromosome 22q13.3 deletion syndrome |PSAP2, PROSAP2, KIAA1650|22q13.3
Colorectal cancer |EP300| 22q13
Conotruncal cardiac anomalies |CTHM| 22q11
Costello syndrome |CTLO|22q13.1
Deafness, autosomal dominant 17, |MYH9, MHA, FTNS, DFNA17|22q11.2
Debrisoquine sensitivity |CYP2D@, CYP2D, P450C2D|22q13.1
Dermatofibrosarcoma protuberans |PDGFB, SIS| 22q12.3-q13.1
DiGeorge syndrome |DGCR, DGS, VCF|22q11
Epilepsy, partial, with variable foci |FPEVF|22q11-q12
Epstein syndrome |MYH9, MHA, FTNS, DFNA17| 22q11.2
Ewing sarcoma |EWSR1, EWS|22q12
Fechtner syndrome,|MYH9, MHA, FTNS, DFNA17|22q11.2
[Gamma-glutamyltransferase, familial high serum]|GGT2|22q11.1
Giant platelet disorder, isolated |GP1BB|22q11.2
Giant-cell fibroblastoma |PDGFB, SIS|22q12.3-q13.1
Glucose/galactose malabsorption|SLC5A1, SGLT1|22q13.1
Glutathioninuria|GGT1, GTG|22q11.1-q11.2
Heme oxygenase-1 deficiency |HMOX1|22q12
Heparin cofactor 2 deficiency |SERPIND1|22q11
Hermansky-Pudlak syndrome|HPS4|22q11.2-q12.2
Hyperprolinemia, type I|PRODH, PRODH2|22q11.2
Insulinoma |ITS|22q12.1-q12.2
Kanzaki disease|NAGA|22q11
Leukemia, chronic myeloid (3), Leukemia, acute lymphocytic|BCR, CML, PHL, ALL|22q11.21
Li-Fraumeni syndrome|CHEK2, RAD53, CHK2, CDS1|22q12.1
Male infertility due to acrosin deficiency|ACR|22q13-qter
May-Hegglin anomaly |MYH9, MHA, FTNS, DFNA17| 22q11.2
Megakaryoblastic leukemia, acute |MKL1, AMKL, MAL| 22q13
Megalencephalic leukoencephalopathy with subcortical cysts |MLC1, LVM, VL| 22qter
Meningioma|MN1, MGCR|22q12.3-qter
Meningioma, NF2-related, somatic|NF2|22q12.2
Meningioma, SIS-related |PDGFB, SIS|22q12.3-q13.1
Metachromatic leukodystrophy |ARSA|22q13.31-qter
Methemoglobinemia, type I |DIA1|22q13.31-qter
Methemoglobinemia, type II |DIA1|22q13.31-qter
Myoneurogastrointestinal encephalomyopathy syndrome|ECGF1|22q13.32-qter
NAGA deficiency, mild |NAGA|22q11
Neuroepithelioma |EWSR1, EWS|22q12
Neurofibromatosis, type 2,|NF2|22q12.2
Neutrophil immunodeficiency syndrome |RAC2|22q12.3-q13.2
Opitz G syndrome, type II |OGS2, BBBG2, GBBB2|22q11.2
Osteosarcoma, somatic, |CHEK2, RAD53, CHK2, CDS1|22q12.1
{?Parkinsonism, susceptibility to} |CYP2D@, CYP2D, P450C2D|22q13.1
Prostate cancer, familial |CHEK2, RAD53, CHK2, CDS1|22q12.1
Pulmonary alveolar proteinosis|CSF2RB|22q12.2-q13.1
Rhabdoid predisposition syndrome, familial|SMARCB1, SNF5, INI1, RDT|22q11
Rhabdoid tumors |SMARCB1, SNF5, INI1, RDT|22q11
Schindler disease |NAGA|22q11
{?Schizophrenia, susceptibility to} |PRODH, PRODH2|22q11.2
{?Schizophrenia}, |APOL1|22q12.3
{Schizophrenia, susceptibility to} |COMT|22q11.2
{Schizophrenia} |APOL2|22q12.3
{Schizophrenia} |APOL4|22q12.3
{Schizophrenia} |SCZD4|22q11-q13
Schwannomatosis |NF2|22q12.2
Sebastian syndrome |MYH9, MHA, FTNS, DFNA17|22q11.2
Sorsby fundus dystrophy |TIMP3, SFD|22q12.1-q13.2
Spinocerebellar ataxia-10 |SCA10|22q13
Transcobalamin II deficiency |TCN2, TC2|22q11.2-qter
Velocardiofacial syndrome, |DGCR, DGS, VCF|22q11
Waardenburg-Shah syndrome, |SOX10, WS4|22q13
Waardenburg-Shah syndrome, neurologic variant |SOX10, WS4|22q13
Yemenite deaf-blind hypopigmentation syndrome |SOX10, WS4|22q13
Those who matter don't mind.
Those who mind don't matter.
Reply With Quote